Finance Home - My Yahoo - Yahoo! - Help

Saturday, December 5, 2009, 6:32PM ET - U.S. Markets Closed. Dow  0.22% Nasdaq  0.98%

Hemispherx Biopharma, Inc. (HEB)

On Dec 4: 0.62   0.06 (8.82%)

MORE ON HEB

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Fri, Dec 4, 2009 • Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Hemispherx Biopharma, Inc. (AMEX: HEB) Marketwire (Fri 4:27pm) • Hemispherx Upbeat Despite FDA setback at TheStreet.com (Fri 9:30am) • Hemispherx Needs to Face Reality at TheStreet.com (Fri 9:30am) • Biotech Stock Mailbag: Hemispherx Biopharma at TheStreet.com (Fri 7:00am) Wed, Dec 2, 2009 • [$$] BioFuel Energy Soars 34%; DRDGold Shines at The Wall Street Journal Online (Wed, Dec 2) • Equities Update: Flat Finish as Energies Weigh at Seeking Alpha (Wed, Dec 2) • Geron, StemCells: Late Day Volume Plays at TheStreet.com (Wed, Dec 2) • Rosen Law Firm Announces Class Action Lawsuit Against Hemispherx Biopharma, Inc. Marketwire (Wed, Dec 2) • Biotech Stocks: Dyax, Santarus, CytRx soar; Hemispherx craters at MarketWatch (Wed, Dec 2) • FDA rejects Hemispherx’s chronic fatigue drug Ampligen at bizjournals.com (Wed, Dec 2) • Biotech Stocks: Dyax rockets, Hemispherx craters on FDA updates at MarketWatch (Wed, Dec 2) • Hemispherx's Ampligen Dealt FDA Blow at TheStreet.com (Wed, Dec 2) • Hemispherx Biopharma Announces Investor Conference Call GlobeNewswire (Wed, Dec 2) • FDA Approves Two New Drugs: BioBuzz at TheStreet.com (Wed, Dec 2) • Hemispherx gets FDA denial on Ampligen treatment AP (Wed, Dec 2) Tue, Dec 1, 2009 • HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online (Tue, Dec 1) • Hemispherx Biopharma Receives Complete Response Letter From FDA on Ampligen(R) New Drug Application for Chronic Fatigue Syndrome GlobeNewswire (Tue, Dec 1) Mon, Nov 23, 2009 • BUYINS.NET Issues Hemispherx Biopharma SqueezeTrigger Report; Over 26 Million Shares Shorted in 2009; Next Short Squeeze Expected Above $1.13 GlobeNewswire (Mon, Nov 23) Tue, Nov 17, 2009 • Genzyme's Termeer: Worst Biotech CEO of '09 at TheStreet.com (Tue, Nov 17) Mon, Nov 16, 2009 • Class Action Lawsuit Against Hemispherx Biopharma is Without Merit GlobeNewswire (Mon, Nov 16) Older Headlines - Download Recent Headlines View headlines from: Mon, Nov 16, 2009Mon, Nov 9, 2009Mon, Nov 2, 2009Mon, Oct 26, 2009Mon, Oct 19, 2009Mon, Oct 12, 2009Mon, Oct 5, 2009Mon, Sep 28, 2009Mon, Sep 21, 2009Mon, Sep 14, 2009 Add HEB News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage